Business of Medicine
Latest News
Oregon Physician Assistants Get Name Change
In June, Oregon PAs will be referred to as Physician Associates, a title change from Physician Assistants being debated nationwide.
Latest News
How These Young MDs Impressed the Hell Out of Their Bosses
Young doctors who got noticed shared their goals, followed through on their career passions, and made patients feel heard.
Feature
Federal Trade Commission Bans Noncompete Agreements, Urges More Protections for Healthcare Workers
But dissenting commissioners dispute the FTC’s authority to broadly ban noncompetes.
Latest News
Are Women Better Doctors Than Men?
Study finds female hospitalists provided better care, defined as lower 30-day mortality, than male hospitalists.
The Optimized Doctor
How to Play Like a Masters Champ
The ability to compartmentalize is useful not only to become Masters champion, but also to become master of your day.
Commentary
Weighing the Benefits of Integrating AI-based Clinical Notes Into Your Practice
Artificial intelligence expert Arturo Loaiza-Bonilla, MD, discusses the benefits of AI-based clinical notes.
Feature
New Federal Rule Delivers Workplace Support, Time Off for Pregnant Docs
Newly updated guidelines for the federal Pregnant Workers Fairness Act could help physicians better balance career and family.
Latest News
AI Surpasses Harvard Docs on Clinical Reasoning Test
When compared to residents, AI more often used incorrect reasoning but overall scored higher in simulated cases, says a recent study.
Latest News
Combined Pediatric Derm-Rheum Clinics Supported by Survey Respondents
Perceived benefits of combined clinics were improved patient care through coordinated treatment decisions and timely communication between...
Managing Your Practice
Burnout
In last month’s column, I discussed employees who are “clock watchers” and how to address this issue in your practice if it exists. Here’s another...
From the Journals
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...